CYRX vs SPIR vs ASTS vs LQDA

For growth investors, AST SpaceMobile, Inc.

(ASTS) is the stronger pick with 1505% revenue growth year-over-year, versus -35. 2% for Spire Global, Inc. (SPIR). Cryoport, Inc. (CYRX) offers the better valuation at 9. 1x trailing P/E, making it the more compelling value choice. Analysts rate Cryoport, Inc. (CYRX) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cryoport, Inc.

(CYRX) is the cheapest at 9. 1x versus Spire Global, Inc. at 10. 0x.

Over the past 5 years, Liquidia Corporation (LQDA) delivered a total return of +1495%, compared to -79.

8% for Cryoport, Inc. (CYRX). Over 10 years, the gap is even starker: ASTS returned +568. 8% versus SPIR's -78. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Liquidia Corporation (LQDA) is the lower-risk stock at 1.

24β versus Spire Global, Inc. 's 2. 93β — meaning SPIR is approximately 137% more volatile than LQDA relative to the S&P 500. On balance sheet safety, AST SpaceMobile, Inc. (ASTS) carries a lower debt/equity ratio of 1% versus 158% for Liquidia Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), AST SpaceMobile, Inc.

(ASTS) is pulling ahead at 1505% versus -35. 2% for Spire Global, Inc. (SPIR). On earnings-per-share growth, the picture is similar: Cryoport, Inc. grew EPS 163. 3% year-over-year, compared to -37. 2% for Liquidia Corporation. Over a 3-year CAGR, ASTS leads at 72. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Spire Global, Inc.

(SPIR) is the more profitable company, earning 71. 7% net margin versus -931. 7% for Liquidia Corporation — meaning it keeps 71. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CYRX leads at -20. 9% versus -866. 6% for LQDA. At the gross margin level — before operating expenses — LQDA leads at 58. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for ASTS: 58.

6% to $103. 65.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Liquidia Corporation (LQDA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

24), +280. 9% 10Y return). Spire Global, Inc. (SPIR) carries a higher beta of 2. 93 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LQDA: +280. 9%, SPIR: -78. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CYRX (Industrials) and SPIR (Industrials) and ASTS (Technology) and LQDA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CYRX is a small-cap deep-value stock; SPIR is a large-cap deep-value stock; ASTS is a mid-cap high-growth stock; LQDA is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.